The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The association between pre-treatment serum 25-hydroxyvitamin D and survival in stage IV prostate cancer.
Pankaj G. Vashi
No relevant relationships to disclose
Digant Gupta
No relevant relationships to disclose
Kristen Trukova
No relevant relationships to disclose
Gwendolyn M Lambert
No relevant relationships to disclose
Carolyn Lammersfeld
No relevant relationships to disclose